Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, November 30, 2020
After a one-year construction phase, Syntegon Technology inaugurated its new OSD Customer Center in Waiblingen, Germany.
read more
Wednesday, February 11, 2026
Syngene International announced a strategic collaboration with Johns Hopkins University, MD, U.S., to advance early stage drug discovery programs and platform technologies emerging from the university’s research labs.
read more
As part of the agreement, Syngene will set-up a customized discovery research laboratory to support projects across several therapeutic areas.
read more
Wednesday, January 21, 2026
Syngene International announced the extension of its long-standing strategic collaboration with Bristol Myers Squibb through 2035. The expanded agreement broadens the scope of integrated services across the drug development lifecycle spanning ...
read more
Tuesday, September 06, 2016
Syngene International, one of Asia’s largest R&D focused contract research organizations, has announced the establishment in Bangalore, India, of an integrated, multi-disciplinary drug discovery and development center for Amgen, Inc.
read more
Syngene International, a global contract research, development and manufacturing organization (CRDMO), announced that its newly upgraded biologics facility - Unit 3 - would be operational for clinical and commercial supply in the second half of 2024.
read more
Syngene International announced the acquisition of its first biologics site in the USA – fitted with multiple monoclonal antibody (mAbs) manufacturing lines.
read more
Synexus, a Site Management Organization (SMO), dedicated to the recruitment of patients’ and hands-on conduct of clinical trials on behalf of pharmaceutical, biotech and CRO clients, has opened a new Dedicated Clinical Research Site in Frankfurt.
read more
On 28th May, 2014, Synexus officially opened a new state of the art clinical trial centre in Bochum, Germany. The clinic which moved from a much smaller site in Bochum started operations at the beginning of May. Situated in the historic Kortum House,...
read more
Tuesday, October 08, 2024
Synexa Life Sciences, a specialist biomarker and bioanalysis service provider, announces the acquisition of Alderley Analytical Ltd, based near Manchester, UK.
read more
Shares of Synergy Pharmaceuticals jumped 47% on encouraging, late-state study results for its constipation drug.
read more
Synergy Pharmaceuticals has entered into a license agreement with Luoxin Pharmaceutical.
read more
Wednesday, February 27, 2019
Synergy confirmed that the previously announced agreement with Bausch Health Companies has been designated as the highest and best offer for Synergy's assets, including all rights to TRULANCE®.
read more
Wednesday, February 02, 2022
Syner-G BioPharma Group announced the acquisition of Impact Pharmaceutical Services. Based in Research Triangle Park, NC, IMPACT supports the outsourced medical writing, regulatory strategy, and regulatory publishing and submission needs of biotech ...
read more
Syneos Health and Elligo Health Research are entering a strategic collaboration to mobilize a system of accelerated research to reach real-world patients.
read more